Physician profile
Cindy Lin
NPI 1376262113
$814.59
in general payments reported to CMS, 2019-2025
16 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $434 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $326.61 | 2024-2025 | Eterna, Proclaim |
| Abbvie INC. | $58.08 | 2024-2025 | |
| Stryker Corporation | $55.18 | 2024 | Trevo |
| Alexion Pharmaceuticals, INC. | $51.50 | 2024-2025 | Ultomiris |
| Biogen, INC. | $46.48 | 2025 | Skyclarys |
| Ucb, INC. | $35.52 | 2024 | Zilbrysq |
| Argenx US, INC. | $34.44 | 2025 | Vyvgart Hytrulo |
| Janssen Biotech, INC. | $29.41 | 2025 | |
| Lundbeck LLC | $28.02 | 2025 | Vyepti |
| Genentech USA, INC. | $25.75 | 2025 | Ocrevus Zunovo |
| Takeda Pharmaceuticals U.S.A., INC. | $23.89 | 2024 | Hyqvia |
| Sk Life Science, INC. | $22.28 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.10 | 2024 | Andexxa |
| Medtronic, INC. | $20.66 | 2024 | Synchromedii |
| Ceribell, INC. | $18.57 | 2024 | Pocket Eeg Device |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $17.10 | 2024 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.